Growing evidence supports the notion that impaired BMP9/10 signaling caused by heterogeneous mutation of ALK1 or ENG results in the decrease of BMP9/10-responsive gene expression and this causes HHT phenotypes. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.